DOI: 10.1016/j.bbrc.2006.04.119. Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2

Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2

10.1016/j.bbrc.2006.04.119

Crossref journal-article

Elsevier BV

Biochemical and Biophysical Research Communications (78)

Bibliography

Miao, H.-Q., Hu, K., Jimenez, X., Navarro, E., Zhang, H., Lu, D., Ludwig, D. L., Balderes, P., & Zhu, Z. (2006). Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2. Biochemical and Biophysical Research Communications, 345(1), 438â445.

Authors 9

Hua-Quan Miao (first)
Kun Hu (additional)
Xenia Jimenez (additional)
Elizabeth Navarro (additional)
Haifan Zhang (additional)
Dan Lu (additional)
Dale L. Ludwig (additional)
Paul Balderes (additional)
Zhenping Zhu (additional)

References 48 Referenced 67

10.1038/nature04483 / Nature / Angiogenesis as a therapeutic target by Ferrara (2005)
10.1038/nature04478 / Nature / Angiogenesis in life, disease and medicine by Carmeliet (2005)
10.1016/S1350-9462(02)00043-5 / Prog. Retin. Eye Res. / Vascular endothelial growth factors and angiogenesis in eye disease by Witmer (2003)
{'key': '10.1016/j.bbrc.2006.04.119_bib4', 'first-page': '209', 'article-title': 'The role of VEGF in the regulation of physiological and pathological angiogenesis', 'author': 'Ferrara', 'year': '2005', 'journal-title': 'Exs'} / Exs / The role of VEGF in the regulation of physiological and pathological angiogenesis by Ferrara (2005)
10.1247/csf.26.25 / Cell Struct. Funct. / Structure and function of VEGF/VEGF-receptor system involved in angiogenesis by Shibuya (2001)
10.1006/scbi.1998.0091 / Semin. Cancer Biol. / VEGFs, receptors and angiogenesis by Veikkola (1999)
10.1038/362841a0 / Nature / Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo by Kim (1993)
10.1038/nrd1381 / Nat. Rev. Drug Discov. / Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer by Ferrara (2004)
{'key': '10.1016/j.bbrc.2006.04.119_bib9', 'first-page': '5209', 'article-title': 'Anti-vascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors', 'volume': '59', 'author': 'Prewett', 'year': '1999', 'journal-title': 'Cancer Res.'} / Cancer Res. / Anti-vascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors by Prewett (1999)
10.1038/sj.leu.2402831 / Leukemia / Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity by Zhu (2003)
10.1073/pnas.0509069102 / Proc. Natl. Acad. Sci. USA / A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165 by Lee (2005)
{'key': '10.1016/j.bbrc.2006.04.119_bib12', 'first-page': '1324', 'article-title': 'Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo', 'volume': '56', 'author': 'Ramakrishnan', 'year': '1996', 'journal-title': 'Cancer Res.'} / Cancer Res. / Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo by Ramakrishnan (1996)
10.1007/s11912-001-0014-7 / Curr. Oncol. Rep. / Angiozyme: a novel angiogenesis inhibitor by Weng (2001)
{'key': '10.1016/j.bbrc.2006.04.119_bib14', 'first-page': '493', 'article-title': 'Technology evaluation: VEGF Trap (cancer), Regeneron/sanofi-aventis', 'volume': '7', 'author': 'Lau', 'year': '2005', 'journal-title': 'Curr. Opin. Mol. Ther.'} / Curr. Opin. Mol. Ther. / Technology evaluation: VEGF Trap (cancer), Regeneron/sanofi-aventis by Lau (2005)
10.2174/0929867043455756 / Curr. Med. Chem. / Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy by Underiner (2004)
10.1159/000088479 / Oncology / VEGF as a therapeutic target in cancer by Ferrara (2005)
10.2741/1629 / Front. Biosci. / Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective by Paz (2005)
10.2174/1568009023333881 / Curr. Cancer Drug Targets / Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics by Zhu (2002)
{'key': '10.1016/j.bbrc.2006.04.119_bib19', 'first-page': '3209', 'article-title': 'Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library', 'volume': '58', 'author': 'Zhu', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library by Zhu (1998)
10.1016/S0304-3835(98)00324-3 / Cancer Lett. / Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody by Zhu (1999)
{'key': '10.1016/j.bbrc.2006.04.119_bib21', 'first-page': '474', 'article-title': 'Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy', 'volume': '43', 'author': 'McLeod', 'year': '2002', 'journal-title': 'Invest. Ophthalmol. Vis. Sci.'} / Invest. Ophthalmol. Vis. Sci. / Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy by McLeod (2002)
10.1002/ijc.1634 / Int. J. Cancer / Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for anti-angiogenesis therapy by Lu (2002)
10.1074/jbc.M307742200 / J. Biol. Chem. / Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity by Lu (2003)
10.1074/jbc.275.19.14321 / J. Biol. Chem. / Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies by Lu (2000)
10.1242/jcs.01138 / J. Cell Sci. / Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C by Persaud (2004)
10.1023/A:1006094117427 / Cancer Metastasis Rev. / Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy by Witte (1998)
10.1016/S0021-9258(18)47116-5 / J. Biol. Chem. / Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor by Waltenberger (1994)
10.1074/jbc.270.12.6729 / J. Biol. Chem. / Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation by Guo (1995)
10.1074/jbc.273.46.30336 / J. Biol. Chem. / Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation by Gerber (1998)
10.1038/sj.onc.1201047 / Oncogene / The 230kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts by Takahashi (1997)
10.1042/bj3530503 / Biochem. J. / Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-δ and by mobilization of intracellular Ca2+ by Gliki (2001)
10.1038/sj.onc.1202527 / Oncogene / VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells by Takahashi (1999)
10.1073/pnas.90.16.7533 / Proc. Natl. Acad. Sci. USA / Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium by Quinn (1993)
{'key': '10.1016/j.bbrc.2006.04.119_bib34', 'first-page': 'H586', 'article-title': 'Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries', 'volume': '265', 'author': 'Ku', 'year': '1993', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries by Ku (1993)
{'key': '10.1016/j.bbrc.2006.04.119_bib35', 'first-page': 'H687', 'article-title': 'Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway', 'volume': '273', 'author': 'Bates', 'year': '1997', 'journal-title': 'Am. J. Physiol.'} / Am. J. Physiol. / Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway by Bates (1997)
10.1152/ajpcell.2001.281.5.C1448 / Am. J. Physiol. Cell Physiol. / Role of PLCgamma and Ca(2+) in VEGF- and FGF-induced choroidal endothelial cell proliferation by McLaughlin (2001)
10.1152/ajpcell.1999.276.1.C176 / Am. J. Physiol. / KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells by Cunningham (1999)
10.1074/jbc.M103130200 / J. Biol. Chem. / Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively by Zeng (2001)
10.1016/S1359-6446(01)01759-7 / Drug Discov. Today / Monoclonal antibody strategies to block angiogenesis by Hicklin (2001)
10.1172/JCI200318740 / J. Clin. Invest. / Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development by Zimmermann (2003)
10.1210/endo.143.7.8896 / Endocrinology / Administration of anti-vascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey by Zimmermann (2002)
10.1053/j.seminoncol.2004.09.026 / Semin. Oncol. / Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer by Collins (2005)
10.1097/00004397-200404430-00005 / Int. Ophthalmol. Clin. / Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration by Barouch (2004)
{'key': '10.1016/j.bbrc.2006.04.119_bib44', 'first-page': '366', 'article-title': 'Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor', 'volume': '11', 'author': 'Kinose', 'year': '2005', 'journal-title': 'Mol. Vis.'} / Mol. Vis. / Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor by Kinose (2005)
10.1001/archopht.120.3.338 / Arch. Ophthalmol. / Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment by Krzystolik (2002)
10.1016/j.ophtha.2005.01.043 / Ophthalmology / Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration by Rosenfeld (2005)
10.1517/14656566.6.8.1421 / Expert Opin. Pharmacother. / Pegaptanib: the first anti-angiogenic agent approved for neovascular macular degeneration by Doggrell (2005)
10.1056/NEJMoa042760 / N. Engl. J. Med. / Pegaptanib for neovascular age-related macular degeneration by Gragoudas (2004)

Dates

Type	When
Created	19 years, 3 months ago (May 5, 2006, 1:51 a.m.)
Deposited	4 years, 1 month ago (July 26, 2021, 1:11 p.m.)
Indexed	11 months, 2 weeks ago (Sept. 16, 2024, 9:15 a.m.)
Issued	19 years, 3 months ago (June 1, 2006)
Published	19 years, 3 months ago (June 1, 2006)
Published Print	19 years, 3 months ago (June 1, 2006)

Funders 0

None

BibTeX

@article{Miao_2006, title={Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2}, volume={345}, ISSN={0006-291X}, url={http://dx.doi.org/10.1016/j.bbrc.2006.04.119}, DOI={10.1016/j.bbrc.2006.04.119}, number={1}, journal={Biochemical and Biophysical Research Communications}, publisher={Elsevier BV}, author={Miao, Hua-Quan and Hu, Kun and Jimenez, Xenia and Navarro, Elizabeth and Zhang, Haifan and Lu, Dan and Ludwig, Dale L. and Balderes, Paul and Zhu, Zhenping}, year={2006}, month=jun, pages={438–445} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        9,
        16
      ]
    ],
    "date-time": "2024-09-16T13:15:48Z",
    "timestamp": 1726492548704
  },
  "reference-count": 48,
  "publisher": "Elsevier BV",
  "issue": "1",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2006,
            6,
            1
          ]
        ],
        "date-time": "2006-06-01T00:00:00Z",
        "timestamp": 1149120000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2006,
        6
      ]
    ]
  },
  "DOI": "10.1016/j.bbrc.2006.04.119",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2006,
        5,
        5
      ]
    ],
    "date-time": "2006-05-05T05:51:57Z",
    "timestamp": 1146808317000
  },
  "page": "438-445",
  "source": "Crossref",
  "is-referenced-by-count": 67,
  "title": "Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2",
  "prefix": "10.1016",
  "volume": "345",
  "author": [
    {
      "given": "Hua-Quan",
      "family": "Miao",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Kun",
      "family": "Hu",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Xenia",
      "family": "Jimenez",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Elizabeth",
      "family": "Navarro",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Haifan",
      "family": "Zhang",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Dan",
      "family": "Lu",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Dale L.",
      "family": "Ludwig",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Paul",
      "family": "Balderes",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Zhenping",
      "family": "Zhu",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "967",
      "DOI": "10.1038/nature04483",
      "article-title": "Angiogenesis as a therapeutic target",
      "volume": "438",
      "author": "Ferrara",
      "year": "2005",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "932",
      "DOI": "10.1038/nature04478",
      "article-title": "Angiogenesis in life, disease and medicine",
      "volume": "438",
      "author": "Carmeliet",
      "year": "2005",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S1350-9462(02)00043-5",
      "article-title": "Vascular endothelial growth factors and angiogenesis in eye disease",
      "volume": "22",
      "author": "Witmer",
      "year": "2003",
      "journal-title": "Prog. Retin. Eye Res."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib4",
      "first-page": "209",
      "article-title": "The role of VEGF in the regulation of physiological and pathological angiogenesis",
      "author": "Ferrara",
      "year": "2005",
      "journal-title": "Exs"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "DOI": "10.1247/csf.26.25",
      "article-title": "Structure and function of VEGF/VEGF-receptor system involved in angiogenesis",
      "volume": "26",
      "author": "Shibuya",
      "year": "2001",
      "journal-title": "Cell Struct. Funct."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "DOI": "10.1006/scbi.1998.0091",
      "article-title": "VEGFs, receptors and angiogenesis",
      "volume": "9",
      "author": "Veikkola",
      "year": "1999",
      "journal-title": "Semin. Cancer Biol."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib7",
      "doi-asserted-by": "crossref",
      "first-page": "841",
      "DOI": "10.1038/362841a0",
      "article-title": "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo",
      "volume": "362",
      "author": "Kim",
      "year": "1993",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "391",
      "DOI": "10.1038/nrd1381",
      "article-title": "Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer",
      "volume": "3",
      "author": "Ferrara",
      "year": "2004",
      "journal-title": "Nat. Rev. Drug Discov."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib9",
      "first-page": "5209",
      "article-title": "Anti-vascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors",
      "volume": "59",
      "author": "Prewett",
      "year": "1999",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "604",
      "DOI": "10.1038/sj.leu.2402831",
      "article-title": "Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity",
      "volume": "17",
      "author": "Zhu",
      "year": "2003",
      "journal-title": "Leukemia"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "18902",
      "DOI": "10.1073/pnas.0509069102",
      "article-title": "A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165",
      "volume": "102",
      "author": "Lee",
      "year": "2005",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib12",
      "first-page": "1324",
      "article-title": "Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo",
      "volume": "56",
      "author": "Ramakrishnan",
      "year": "1996",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "141",
      "DOI": "10.1007/s11912-001-0014-7",
      "article-title": "Angiozyme: a novel angiogenesis inhibitor",
      "volume": "3",
      "author": "Weng",
      "year": "2001",
      "journal-title": "Curr. Oncol. Rep."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib14",
      "first-page": "493",
      "article-title": "Technology evaluation: VEGF Trap (cancer), Regeneron/sanofi-aventis",
      "volume": "7",
      "author": "Lau",
      "year": "2005",
      "journal-title": "Curr. Opin. Mol. Ther."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "731",
      "DOI": "10.2174/0929867043455756",
      "article-title": "Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy",
      "volume": "11",
      "author": "Underiner",
      "year": "2004",
      "journal-title": "Curr. Med. Chem."
    },
    {
      "issue": "Suppl. 3",
      "key": "10.1016/j.bbrc.2006.04.119_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "DOI": "10.1159/000088479",
      "article-title": "VEGF as a therapeutic target in cancer",
      "volume": "69",
      "author": "Ferrara",
      "year": "2005",
      "journal-title": "Oncology"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "1415",
      "DOI": "10.2741/1629",
      "article-title": "Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective",
      "volume": "10",
      "author": "Paz",
      "year": "2005",
      "journal-title": "Front. Biosci."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "DOI": "10.2174/1568009023333881",
      "article-title": "Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics",
      "volume": "2",
      "author": "Zhu",
      "year": "2002",
      "journal-title": "Curr. Cancer Drug Targets"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib19",
      "first-page": "3209",
      "article-title": "Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library",
      "volume": "58",
      "author": "Zhu",
      "year": "1998",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "DOI": "10.1016/S0304-3835(98)00324-3",
      "article-title": "Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody",
      "volume": "136",
      "author": "Zhu",
      "year": "1999",
      "journal-title": "Cancer Lett."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib21",
      "first-page": "474",
      "article-title": "Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy",
      "volume": "43",
      "author": "McLeod",
      "year": "2002",
      "journal-title": "Invest. Ophthalmol. Vis. Sci."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "393",
      "DOI": "10.1002/ijc.1634",
      "article-title": "Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for anti-angiogenesis therapy",
      "volume": "97",
      "author": "Lu",
      "year": "2002",
      "journal-title": "Int. J. Cancer"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "43496",
      "DOI": "10.1074/jbc.M307742200",
      "article-title": "Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity",
      "volume": "278",
      "author": "Lu",
      "year": "2003",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "14321",
      "DOI": "10.1074/jbc.275.19.14321",
      "article-title": "Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies",
      "volume": "275",
      "author": "Lu",
      "year": "2000",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "2745",
      "DOI": "10.1242/jcs.01138",
      "article-title": "Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C",
      "volume": "117",
      "author": "Persaud",
      "year": "2004",
      "journal-title": "J. Cell Sci."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "155",
      "DOI": "10.1023/A:1006094117427",
      "article-title": "Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy",
      "volume": "17",
      "author": "Witte",
      "year": "1998",
      "journal-title": "Cancer Metastasis Rev."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "26988",
      "DOI": "10.1016/S0021-9258(18)47116-5",
      "article-title": "Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor",
      "volume": "269",
      "author": "Waltenberger",
      "year": "1994",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "6729",
      "DOI": "10.1074/jbc.270.12.6729",
      "article-title": "Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation",
      "volume": "270",
      "author": "Guo",
      "year": "1995",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "30336",
      "DOI": "10.1074/jbc.273.46.30336",
      "article-title": "Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation",
      "volume": "273",
      "author": "Gerber",
      "year": "1998",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib30",
      "doi-asserted-by": "crossref",
      "first-page": "2079",
      "DOI": "10.1038/sj.onc.1201047",
      "article-title": "The 230kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-\u03b3 pathway and partially induces mitotic signals in NIH3T3 fibroblasts",
      "volume": "14",
      "author": "Takahashi",
      "year": "1997",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib31",
      "doi-asserted-by": "crossref",
      "first-page": "503",
      "DOI": "10.1042/bj3530503",
      "article-title": "Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-\u03b4 and by mobilization of intracellular Ca2+",
      "volume": "353",
      "author": "Gliki",
      "year": "2001",
      "journal-title": "Biochem. J."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "2221",
      "DOI": "10.1038/sj.onc.1202527",
      "article-title": "VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells",
      "volume": "18",
      "author": "Takahashi",
      "year": "1999",
      "journal-title": "Oncogene"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "7533",
      "DOI": "10.1073/pnas.90.16.7533",
      "article-title": "Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium",
      "volume": "90",
      "author": "Quinn",
      "year": "1993",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib34",
      "first-page": "H586",
      "article-title": "Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries",
      "volume": "265",
      "author": "Ku",
      "year": "1993",
      "journal-title": "Am. J. Physiol."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib35",
      "first-page": "H687",
      "article-title": "Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway",
      "volume": "273",
      "author": "Bates",
      "year": "1997",
      "journal-title": "Am. J. Physiol."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib36",
      "doi-asserted-by": "crossref",
      "first-page": "C1448",
      "DOI": "10.1152/ajpcell.2001.281.5.C1448",
      "article-title": "Role of PLCgamma and Ca(2+) in VEGF- and FGF-induced choroidal endothelial cell proliferation",
      "volume": "281",
      "author": "McLaughlin",
      "year": "2001",
      "journal-title": "Am. J. Physiol. Cell Physiol."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "C176",
      "DOI": "10.1152/ajpcell.1999.276.1.C176",
      "article-title": "KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells",
      "volume": "276",
      "author": "Cunningham",
      "year": "1999",
      "journal-title": "Am. J. Physiol."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "32714",
      "DOI": "10.1074/jbc.M103130200",
      "article-title": "Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively",
      "volume": "276",
      "author": "Zeng",
      "year": "2001",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib39",
      "doi-asserted-by": "crossref",
      "first-page": "517",
      "DOI": "10.1016/S1359-6446(01)01759-7",
      "article-title": "Monoclonal antibody strategies to block angiogenesis",
      "volume": "6",
      "author": "Hicklin",
      "year": "2001",
      "journal-title": "Drug Discov. Today"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "659",
      "DOI": "10.1172/JCI200318740",
      "article-title": "Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development",
      "volume": "112",
      "author": "Zimmermann",
      "year": "2003",
      "journal-title": "J. Clin. Invest."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib41",
      "doi-asserted-by": "crossref",
      "first-page": "2496",
      "DOI": "10.1210/endo.143.7.8896",
      "article-title": "Administration of anti-vascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey",
      "volume": "143",
      "author": "Zimmermann",
      "year": "2002",
      "journal-title": "Endocrinology"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "DOI": "10.1053/j.seminoncol.2004.09.026",
      "article-title": "Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer",
      "volume": "32",
      "author": "Collins",
      "year": "2005",
      "journal-title": "Semin. Oncol."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "DOI": "10.1097/00004397-200404430-00005",
      "article-title": "Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration",
      "volume": "44",
      "author": "Barouch",
      "year": "2004",
      "journal-title": "Int. Ophthalmol. Clin."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib44",
      "first-page": "366",
      "article-title": "Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor",
      "volume": "11",
      "author": "Kinose",
      "year": "2005",
      "journal-title": "Mol. Vis."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib45",
      "doi-asserted-by": "crossref",
      "first-page": "338",
      "DOI": "10.1001/archopht.120.3.338",
      "article-title": "Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment",
      "volume": "120",
      "author": "Krzystolik",
      "year": "2002",
      "journal-title": "Arch. Ophthalmol."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib46",
      "doi-asserted-by": "crossref",
      "first-page": "1048",
      "DOI": "10.1016/j.ophtha.2005.01.043",
      "article-title": "Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration",
      "volume": "112",
      "author": "Rosenfeld",
      "year": "2005",
      "journal-title": "Ophthalmology"
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib47",
      "doi-asserted-by": "crossref",
      "first-page": "1421",
      "DOI": "10.1517/14656566.6.8.1421",
      "article-title": "Pegaptanib: the first anti-angiogenic agent approved for neovascular macular degeneration",
      "volume": "6",
      "author": "Doggrell",
      "year": "2005",
      "journal-title": "Expert Opin. Pharmacother."
    },
    {
      "key": "10.1016/j.bbrc.2006.04.119_bib48",
      "doi-asserted-by": "crossref",
      "first-page": "2805",
      "DOI": "10.1056/NEJMoa042760",
      "article-title": "Pegaptanib for neovascular age-related macular degeneration",
      "volume": "351",
      "author": "Gragoudas",
      "year": "2004",
      "journal-title": "N. Engl. J. Med."
    }
  ],
  "container-title": "Biochemical and Biophysical Research Communications",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0006291X06008370?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0006291X06008370?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2021,
        7,
        26
      ]
    ],
    "date-time": "2021-07-26T17:11:27Z",
    "timestamp": 1627319487000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0006291X06008370"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2006,
        6
      ]
    ]
  },
  "references-count": 48,
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2006,
          6
        ]
      ]
    }
  },
  "alternative-id": [
    "S0006291X06008370"
  ],
  "URL": "http://dx.doi.org/10.1016/j.bbrc.2006.04.119",
  "relation": {},
  "ISSN": [
    "0006-291X"
  ],
  "subject": [],
  "container-title-short": "Biochemical and Biophysical Research Communications",
  "published": {
    "date-parts": [
      [
        2006,
        6
      ]
    ]
  }
}